Ventyx Biosciences, Inc. (VTYX) has a market capitalization of $1B and trades at $14.00. The 52-week range is 0.783-25.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.1, Earnings Per Share (EPS) of $-1.97.
The stock has a beta of 1.27, operates in the Healthcare sector.
